New York, NY, April 23, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, specializing in sector research issues an investor trading alert for  Biostar Pharmaceuticals, Inc. (NasdaqGM: BSPM), trading at $1.9596, up 0.3096(18.76%) as of 2:44PM EDT on over 390,000 shares . The stock has a high of $2.10 on the day .

  The Company announced that its Shaanxi Weinan subsidiary, acquired in October 2011, won a bid and has been selected as the exclusive supplier of Huangyangning Tablets, a prescription drug used for the treatment of cardiovascular disease, to all hospitals based in the provinces of Liaoning, Hebei and Shandong for up to three years.  Biostar will supply Huangyangning Tablets to these hospitals based on patient needs in each hospital.

Published: 22 April 2012
Written by Investor Ideas
Read more: China Stock Trading Alert: Biostar Pharmaceuticals (NASDAQ:BSPM) up over 18% on News

Gold and The Quality of Life

In this Note we hypothesize that gold has a central place in the resolution of current global economic challenges and in investor portfolios. There are three rationales for this reasoning. They are convergence, deleveraging and the reserve currency status of the dollar.

Written by Michael A. Berry, Ph.D. - [ Discovery Investing Web Site ]

alt

Published: 18 April 2012
Written by Editor
Financial   Research  

Getting Into Graphite: Why First-In Juniors Will Prosper
(Chris Berry Interview with IRJ)

Specialty metals bug Chris Berry, president and founder of House Mountain Partners, says that now is an opportune time for investors to get behind graphite. In fact, when it comes to the demand for sheet metal coming out of Asia and the need for a cheap and affordable source of electricity, “graphite is right in that crosshair.”
It’s never as simple as piling dollars into one player or another

Written by Michael A. Berry, Ph.D. - [ Discovery Investing Web Site ]

alt

Published: 17 April 2012
Written by Editor
Financial   Research  

New York, NY - April 17, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Monday April 16th. The Nasdaq Composite fell 22.93 (-0.76%) to close at 2,988.40.

 Endocyte, Inc. (NASDAQ:ECYT) shares soared $3.82 (100.53%) to end at $7.62

 following news that Merck (NYSE: MRK) and Endocyte entered into an agreement to develop and commercialize Endocyte's novel investigational therapeutic candidate vintafolide (EC145). The stock is continuing its gains this morning in Tuesday’s trading.

Published: 16 April 2012
Written by Investor Ideas
Read more: Monday's NASDAQ Top % Winners: ECYT, HAUP, SAPX, USAT

We are pleased to back home this AM. Last week was a blur. We travelled to several destinations for research and presentations. On Monday Chris and I drove 45 minutes to Asbury, New Jersey to visit CEO Stephen Riddle at Asbury Graphite Mills. Asbury produces a number of unique graphite products (see photos below). The company has been in continuous operation for 117 years. Mr. Riddle’s great grandfather formed the company in 1895 when he turned a local flour mill into a graphite mill. That alone tells you more about the importance of graphite than any issue around graphene today.

Written by Michael A. Berry, Ph.D. - [ Discovery Investing Web Site ]

alt

Published: 16 April 2012
Written by Editor
Mining   Research  
  1. Wednesday's NASDAQ Winners: NEWL, YRCW, TZOO, PWAV
  2. Tech Stock News: Social Networking/Media Stock Directory Updated: Facebook To List in May
  3. Monday's NASDAQ Top % Winners: GAI, ADEP, WOLF, CALL
  4. Tech Stock News: Facebook to Acquire Instagram
  5. Three of the Top Percentage Gainers on NASDAQ Today are China Cleantech/Renewable Energy Stocks: (CLNT), (CREG), (NFEC)